Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment

Overview of attention for article published in Frontiers in immunology, March 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 98 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 24 publications that cite this research output.

24

The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.

Interleukin 6 Antagonists in Severe COVID-19 Disease: Cardiovascular and Respiratory Outcomes

Article in Protein and Peptide Letters (February 2024)

Analysis of cytokine levels, cytological findings, and MP‐DNA level in bronchoalveolar lavage fluid of children with Mycoplasma pneumoniae pneumonia

Article in Immunity Inflammation and Disease (May 2023)

Influence of polymorphic variations of IFNL, HLA, and IL-6 genes in severe cases of COVID-19

Article in Experimental Biology and Medicine (May 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.